Skip to main content
VulnerabilityPublished

CVE-2026-123052: CIPCarbone Farmasimplex CeliachiaRL · Use of Hard-coded Credentials

Affects CIPCarbone Farmasimplex CeliachiaRLSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 4.7 Medium : upgrade to 16.2.0 when convenient.

Data as of 17 Nov 2026, 14:54 UTC

CVSS 4.0 base score
4.7Medium
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (ENISA)CVSS 4.04.7
Patch
Available – fixed in 16.2.0
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:U

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 17 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.

What to do

Upgrade CIPCarbone Farmasimplex CeliachiaRL to 16.2.0.

Affected software

ProductAffectedFixed in
CIPCarboneFarmasimplex CeliachiaRLAffected
  • <16.2.0
Fixed in
  • 16.2.0

AI-suggested

Upgrade Farmasimplex CeliachiaRL to version 16.2.0 or later, where the use of shared OAuth credentials has been addressed. This official fix eliminates the vulnerability by removing or properly segregating credentials. No additional mitigation is required once the patch is applied.

Description

CIPCarbone Farmasimplex CeliachiaRL integration component uses shared OAuth credentials across multiple customer installations. This hard-coded credential reuse allows an attacker who obtains credentials from one installation to potentially access or modify data in others. The vulnerability affects versions prior to 16.2.0 and has been fixed in version 16.2.0. The CVSS score is 4.7, indicating a medium severity risk.

References

Community reviews

Loading reviews…